Labiotech.eu

Genomics partner Vertex big genomic data

News and Trends 31 Aug 2018

Vertex Partners Oxford Genome Analysis Firm To Develop New Personalized Therapies

Genomics, a company using machine learning to analyze genetic data, is partnering with precision medicine specialists Vertex Pharmaceuticals to develop new therapies in a 3-year collaboration. The agreement marks the closing of the Oxford-based company’s €28M (£25M) series B fundraising round, as Vertex has also invested €11.7M (£10.5M) in Genomics. If the collaboration is successful […]

August 31, 2018 - 2 minutesmins - By Helen Albert

News and Trends 30 Aug 2018

First RNAi Drug Approved in Europe After 20 Years of Research

The first ever RNA interference (RNAi) drug, used to treat polyneuropathy in patients with hereditary transthyretin-mediated amyloidosis, has been given marketing approval by the European Commision. The approval follows that of the US FDA who gave the green light to US biotech Alnylam Pharmaceutical’s Onpattro (patisiran) earlier this month following positive Phase III findings in […]

August 30, 2018 - 3 minutesmins - By Helen Albert

Expert Advice 30 Aug 2018

7 Ingredients a Life Science Infographic Needs to Go Viral

Infographics enjoyed a hay day in the early 2010s. They were a fresh idea and a welcome change to the standard blog post format which the internet was already flooded with. They worked so well in catching the consumers’ attention, that their decline came as quickly as their rise. As with any new medium, […]

August 30, 2018 - 9 minutesmins - By James Mathison

News and Trends 29 Aug 2018

Women’s Health Biotech Raises €28M to Fund Phase II Menopause Drug Trial

UK-biotech KaNDy Therapeutics closed a £25M (€28M) series C round to help finance the upcoming Phase IIb trial of its lead candidate for treating symptoms of the menopause. Unlike other therapies aimed at treating the same symptoms, KaNDy’s drug (NT-814) is not based on hormone replacement therapy, which can take a long time to be […]

August 29, 2018 - 2 minutesmins - By Helen Albert

News and Trends 29 Aug 2018

Affimed Collaborates with Genentech in Cancer Immunotherapy Deal Worth €4.4B

The German biotech will partner with Genentech, part of the Roche Group, to develop targeted cancer therapies that engage both innate and adaptive immune cells. Affimed will receive €82M ($96M) upfront from the US giant to develop its immunotherapy ROCK (Redirected Optimized Cell Killing) platform, which uses both natural killer cells and T-cells to target […]

August 29, 2018 - 2 minutesmins - By Helen Albert

In Depth 29 Aug 2018

How Big is the Investment Gap Between Biotech and Digital? (Smaller Than You Think…)

Many people outside of biotech may wonder how the size of the biotech industry compares to the digital industry, and even biotech experts often don’t know the answer. Here we’ll take a look at how the two industries compare and how they are expected to develop in the future. We cannot get around the fact […]

August 29, 2018 - 7 minutesmins - By Editorial Team

News and Trends 28 Aug 2018

Update: Gilead and Novartis’s CAR T-Cell Therapies Approved in Europe

Update: Following on from earlier approvals in the US, the European Commission announced it has given marketing approval for both Gilead’s Yescarta and Novartis’s Kymriah for treatment of patients with various forms of blood cancer. Yescarta (axicabtagene ciloleucel) can be used to treat adults with a relapsed or refractory form of the blood cancer diffuse large […]

August 28, 2018 - 4 minutesmins - By Editorial Team

News and Trends 25 Aug 2018

Are Fungi the Answer to a More Sustainable Future?

The exhibition Fungal Futures, in Belgium, showcases multiple objects that are made using fungi, offering a peek into a future of sustainable materials. We are in dire need of sustainable materials that provide an environmentally-friendly alternative to plastic and other materials that cause pollution and end up crowding landfills. The solution could be fungi. These […]

August 25, 2018 - 5 minutesmins - By Clara Rodríguez Fernández

More News! 24 Aug 2018

Shire gets US market approval for rare inflammatory disease drug

The UK-US biotech giant’s drug Takhzyro has been approved by the FDA to prevent attacks of hereditary angioedema, a rare genetic disease that causes swelling around the body. Hereditary angioedema is a potentially life threatening genetic condition that people can inherit from either of their parents. Takhzyro (lanadelumab-flyo) is a first-in-class monoclonal antibody drug that […]

August 24, 2018 - 2 minutesmins - By Helen Albert

News and Trends 22 Aug 2018

Swedish Biotech Breaks Barrier to Diagnosis with Rheumatoid Arthritis Test

A blood test developed by Swedish-biotech Immunovia and scientists from Linköping University accurately diagnoses patients with rheumatoid arthritis even if they test negative for two common biomarkers. The current gold standard test for rheumatoid arthritis, which affects 5-7 million people in the US and Europe, misses a substantial number of people who have the condition. […]

August 22, 2018 - 2 minutesmins - By Helen Albert

sea view plus seaweed marine biofuel news

More News! 22 Aug 2018

Producing Cost-Effective and Eco-Friendly Biofuel With Seawater

UK researchers have developed a technique for making bioethanol from seawater, which they hope will make production of the biofuel cheaper and more environmentally friendly than current methods. At present, bioethanol production uses very large amounts of freshwater – 1000-10,000 liters water per 1 liter bioethanol. They also require large amounts of plant biomass to […]

August 22, 2018 - 3 minutesmins - By Helen Albert

Best in Biotech 20 Aug 2018

Here are our 10 favorite biotech books you should read this summer

Here is a list of our 10 best biotech books for you, ranging from new and classic popular science to science fiction, as selected by the team at Labiotech. The summer is sadly coming to a close very soon, but we wanted to provide you with a bit more Labiotech entertainment for its last few weeks. I […]

August 20, 2018 - 9 minutesmins - By Helen Albert

Knowledge hub

Categories

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

These 7 biotechs are shaping the next generation of endometriosis care

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Vertex Partners Oxford Genome Analysis Firm To Develop New Personalized Therapies

First RNAi Drug Approved in Europe After 20 Years of Research

7 Ingredients a Life Science Infographic Needs to Go Viral

Women’s Health Biotech Raises €28M to Fund Phase II Menopause Drug Trial

Affimed Collaborates with Genentech in Cancer Immunotherapy Deal Worth €4.4B

How Big is the Investment Gap Between Biotech and Digital? (Smaller Than You Think…)

Update: Gilead and Novartis’s CAR T-Cell Therapies Approved in Europe

Are Fungi the Answer to a More Sustainable Future?

Shire gets US market approval for rare inflammatory disease drug

Swedish Biotech Breaks Barrier to Diagnosis with Rheumatoid Arthritis Test

Producing Cost-Effective and Eco-Friendly Biofuel With Seawater

Here are our 10 favorite biotech books you should read this summer

Subscribe to our newsletter to get the latest biotech news!

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!